Kimberly D. Morel, MD

Board Certifications: 
Pediatric Dermatology, Pediatrics, Dermatology
Accepting New Patients
Treats Children
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Acne, Atopic Dermatitis, Eczema, Epidermolysis Bullosa, Genetic Skin Disease, Hair Disorder, Hair, Nails, and Skin Conditions, Hemangioma, Laser Surgery, Mole, Molluscum Contagiosum, Pediatric Warts, Psoriasis, Vascular Birthmark, Warts

Academic Appointments

  • Associate Professor of Dermatology and Pediatrics at CUMC

Administrative Titles

  • Director, Epidermolysis Bullosa Interdisciplinary Clinic

Dr. Kimberly Morel is an Associate Professor of Dermatology and Pediatrics at Columbia University Medical Center. She joined the staff of NewYork-Presbyterian Morgan Stanley Children's Hospital in 2003.

Dr. Morel received her undergraduate degree from the University of Pennsylvania and her medical degree from SUNY Health Science Center at Brooklyn, New York.  She completed her residency training in both Pediatrics and Dermatology at the New York Presbyterian Hospital/Columbia University and was a fellow in Pediatric and Adolescent Dermatology at the Children's Hospital, San Diego, University of California, San Diego. She is board certified in Pediatrics, Dermatology as well as Pediatric Dermatology.

Dr. Morel directs the Pediatric Epidermolysis Bullosa (EB) Interdisciplinary Clinic at Columbia. The EB Clinic, which was initiated by Dr. Morel in June 2007, provides comprehensive outpatient consultation, consisting of various sub-specialists, such as dermatologists, occupational and physical tharapists, nutritionists, and social workers, who have expertise in treating the multiple aspects of EB. She is a also a member of the Vascular Anomalies Clinic (VAC) and the Pediatric Cutaneous Oncology Clinic (PCOC). Dr. Morel performs pulsed dye laser therapy for vascular birthmarks. She is the author of several articles and book chapters regarding skin conditions in pediatric patients.

Dr. Morel is a fellow of the American Academy of Dermatology and the American Academy of Pediatrics. She is a member of the Society for Pediatric Dermatology, Hemangioma Investigator Group, the Epidermolysis Bullosa Clinical Research Concortium, and is on the executive committee of the Pediatric Dermatology Research Alliance (PeDRA). 

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Gender

  • Female

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-5293

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary
ColumbiaDoctors Midtown
51 West 51st Street
New York, NY 10019
ColumbiaDoctors Tarrytown
155 White Plains Road
Tarrytown, NY 10591

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • HMO
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • State University of New York - Downstate Health Sciences Center
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: University of California-San Diego Medical Center

Board Certifications

  • Pediatric Dermatology
  • Pediatrics
  • Dermatology
America's Top Doctor
NY Top Doctor

Research

Research Interests

  • Atopic Dermatitis
  • Epidermolysis Bullosa
  • Hemangiomas
  • Pediatric CTCL

Grants

PROSPECTIVE PEDIATRIC LONGITUDINAL EVALUATION TO ASSESS THE LONG-TERM SAFETY OF TACROLIMUS OINTMENT FOR THE TREATMENT OF (P&S Industry Clinical Trial)

Nov 22 2005 - Sep 30 2020

A PROSPECTIVE SHORT TERM STUDY TO EVALUATE METHODOLOGY FOR THE ASSESSMENT OF SKIN INVOLVEMENT AND TO ASSESS DISEASE EXTENT AND IMPACT IN PATIENTS WITH DYSTROPHIC EPIDERMOLYSIS BULLOSA (DEB) (P&S Industry Clinical Trial)

Sep 25 2014 - Sep 25 2019

EBCRC PARTICIPATING CENTER GRANT (Private)

Jul 21 2016 - Jun 30 2017

CHARACTERIZATION OF SKIN CARE PRACTICES AND ANTIMICROBIAL RESISTANCE PATTERNS IN EB: PAVING THE WAY FOR INDIVIDUALIZED TREATMENT AND IDENTIFICATION OF HIGH RISK PATIENTS (Private)

Jul 21 2016 - Jun 30 2017

EPIDEMOLYSIS BULLOSA CLINICAL RESEARCH CONSORTIUM SUB-GRANT (Private)

Aug 5 2015 - Jun 30 2016

HEMANGIOMA EDUCATION ON THE WORLD WIDE WEB (Private)

Jul 15 2012 - Jul 15 2013

EPIDERMOLYSIS BULLOSA CLINICAL RESEARCH CONSORTIUM (Private)

Jan 1 2012 - May 31 2013

PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY OF THE SAFETY AND EFFICACY OF THYMOSIN BETA 4 IN THE TREATMENT OF PATIENTS (P&S Industry Clinical Trial)

Jan 19 2006 - Jun 30 2011